839P Matching-adjusted indirect comparison (MAIC) of axicabtagene ciloleucel (axi-cel) and glofitamab (glofit) in relapsed/refractory (R/R) large B cell lymphoma (LBCL) after at least two prior systemic therapies (3L+)
Year: 2023
Type: article
Source: Annals of Oncology
Authors: F.L. Locke, J.M. Chen, K. Chan, M.D. Ray, I. Zhang, S. Keeping, C. Fu, A.R. Patel, O.O. Oluwole
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4387825993